Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect – Eli Lilly

Written by Charlie King | 21 Mar 2026 | Diabetes & Endocrinology

Eli Lilly and Company announced that access to self-pay pricing on the new Zepbound (tirzepatide) KwikPen for single-patient use will be available at LillyDirect and major pharmacies nationwide, starting at $299 per month for the 2.5 mg dose. This expansion provides people without obesity management medicine insurance coverage with additional ways to access prescribed treatment, whether that’s picking up a prescription as part of their everyday routine at a local pharmacy, or choosing home delivery through LillyDirect.

The new KwikPen Self-Pay Savings Card is available to all patients, including those without insurance coverage. Adults with a valid, on‑label prescription for Zepbound KwikPen can use the savings card to access the same self‑pay prices offered through LillyDirect. The card applies only to the Zepbound KwikPen and does not apply to single-dose vials or the single-dose pen.

Zepbound is an injectable prescription medicine that may help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off. Zepbound may also help adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA. It should be used with a reduced-calorie diet and increased physical activity. Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children. Please see Indications and Safety Summary with Warnings below.

Zepbound is available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg doses. The 2.5 mg is a starting dose and not an approved maintenance dose. The recommended maintenance doses are 5 mg, 10 mg, or 15 mg injected subcutaneously once per week for weight reduction and long-term maintenance. The recommended maintenance doses for OSA are 10 mg or 15 mg.